Qingdao Saber Technology Pharmaceutical: difference between revisions

Diff·revision 8 → 9·02:29, 21 Aug 2025

Difference between revision 8 and revision 9 of Qingdao Saber Technology Pharmaceutical. 17 lines changed; the page grew by 1,063 bytes.

Revision 8 — 15:55, 9 Aug 2025 BlankVialBo (talk) add category for suppliers in China 5,550 bytes +201	Revision 9 — 02:29, 21 Aug 2025 BatchNumberBede (talk) typo 6,613 bytes +1,063
1	{{Infobox organisation	1	{{Infobox organisation
2	\| name = Qingdao Saber Technology Pharmaceutical	2	\| name = Qingdao Saber Technology Pharmaceutical
+		3	\| subtitle = Organisation
3	\| image = facility.svg	4	\| image = facility.svg
4	\| caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.	5	\| caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki.
⋮		⋮
11	\| Industry = Research-compound supply	12	\| Industry = Research-compound supply
12	\| Official site = [https://qingdaosabertechnology.com/ Visit QST at qingdaosabertechnology.com]	13	\| Official site = [https://qingdaosabertechnology.com/ Visit QST at qingdaosabertechnology.com]
+		14	<!-- Products and documentation -->
+		15	\| Product scope = peptides, SARMs, injectable oils and raw materials
+		16	\| Catalogue size = 350+ listings (self-reported)
+		17	\| Documentation = Batch certificate of analysis reported with orders
+		18	\| Independent reports = Submitted to this wiki by purchasers; see §Independent testing record
13	}}	19	}}
14	{{hatnote\|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}}	20	{{hatnote\|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}}
⋮		⋮
32		38
33	No certification claim has been corroborated, and the organisation's own statements about capability are self-published.{{r\|selfpub,gmp}}	39	No certification claim has been corroborated, and the organisation's own statements about capability are self-published.{{r\|selfpub,gmp}}
+		40
+		41	== Product range ==
+		42	\| Class \| Representative listings \| Documentation reported \|
+		43	\|---\|---\|---\|
+		44	\| Incretin analogues \| Semaglutide, tirzepatide \| Certificate with purity and appearance; water on request \|
+		45	\| Research peptides \| Repair and secretagogue peptides \| Certificate with purity \|
+		46	\| SARMs \| Bulk and capsuled \| Certificate with purity \|
+		47	\| Raw materials and oils \| Bulk \| Certificate; specification sheet on request \|
+		48
+		49	== Independent testing record ==
+		50	Submitted reports on QST material to July 2026 are fewer than for the larger entries, reflecting a smaller reported customer base rather than a quality finding.{{r\|reports}} Reported [[Area percent purity\|area percent]] figures have been high in most cases.
34		51
35	== References ==	52	== References ==